BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5869 related articles for article (PubMed ID: 15489140)

  • 21. Lifestyle-related factors and environmental agents causing cancer: an overview.
    Irigaray P; Newby JA; Clapp R; Hardell L; Howard V; Montagnier L; Epstein S; Belpomme D
    Biomed Pharmacother; 2007 Dec; 61(10):640-58. PubMed ID: 18055160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimutagens, anticarcinogens, and effective worldwide cancer prevention.
    Weisburger JH
    J Environ Pathol Toxicol Oncol; 1999; 18(2):85-93. PubMed ID: 15281219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro carcinogenesis with cells in early passage.
    DiPaolo JA; Casto BC
    Natl Cancer Inst Monogr; 1978 May; (48):245-57. PubMed ID: 372816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk.
    Rietjens IM; Boersma MG; van der Woude H; Jeurissen SM; Schutte ME; Alink GM
    Mutat Res; 2005 Jul; 574(1-2):124-38. PubMed ID: 15914212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transplacental and transgenerational carcinogenesis].
    Turusov VS; Tomatis L
    Arkh Patol; 1997; 59(5):7-12. PubMed ID: 9446543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoplastic response of mouse tissues during perinatal age periods and its significance in chemical carcinogenesis.
    Vesselinovitch SD; Rao KV; Mihailovich N
    Natl Cancer Inst Monogr; 1979 May; (51):239-50. PubMed ID: 384263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The carcinogenicity of acrylamide.
    Rice JM
    Mutat Res; 2005 Feb; 580(1-2):3-20. PubMed ID: 15668103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Individual predisposition to lung neoplasm--the role of genes involved in metabolism of carcinogens].
    Butkiewicz D; Chorazy M
    Postepy Hig Med Dosw; 1999; 53(5):655-73. PubMed ID: 10645142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular epidemiology of breast cancer.
    Goldman R; Shields PG
    In Vivo; 1998; 12(1):43-8. PubMed ID: 9575425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach.
    Hernández LG; van Steeg H; Luijten M; van Benthem J
    Mutat Res; 2009; 682(2-3):94-109. PubMed ID: 19631282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vegetables, fruit and phytoestrogens as preventive agents.
    Potter JD; Steinmetz K
    IARC Sci Publ; 1996; (139):61-90. PubMed ID: 8923020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study design and genetic susceptibility factors in the risk assessment of chemical carcinogens.
    Caporaso N
    Ann Ist Super Sanita; 1991; 27(4):621-30. PubMed ID: 1820735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer.
    Groopman JD; Wang JS; Scholl P
    Can J Physiol Pharmacol; 1996 Feb; 74(2):203-9. PubMed ID: 8723033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic effects and biotoxicity monitoring of occupational styrene exposure.
    Rueff J; Teixeira JP; Santos LS; Gaspar JF
    Clin Chim Acta; 2009 Jan; 399(1-2):8-23. PubMed ID: 18845133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA adducts and the mechanism of carcinogenesis and cytotoxicity of methylating agents of environmental and clinical significance.
    Kyrtopoulos SA; Anderson LM; Chhabra SK; Souliotis VL; Pletsa V; Valavanis C; Georgiadis P
    Cancer Detect Prev; 1997; 21(5):391-405. PubMed ID: 9307842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 294.